GLR Partners, LLC

Position in NVO — Novo Nordisk A S

CIK 2134831 COLUMBIA, MD

Position in NVO

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$361,132

+$84,295 QoQ

Shares Held

7,533

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

#826

of 1,348 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLR Partners, LLC holds $5,335,585 across 4 Drug Manufacturers - General names. NVO ranks #4 (6.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,605	$3,124,515
2	JNJ	Johnson & Johnson	5,342	$1,356,707
3	GILD	Gilead Sciences, Inc.	3,904	$493,231
4	NVO	Novo Nordisk A S This page	7,533	$361,132

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$361,132	7,533	0.0%	Shares	Sole	2026-07-27
2026-03-31	$276,837	7,533	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.